Associate Professor of Nanomedicine, Institute for Academic Medicine
Associate Member, Research Institute
Director, Center for Orthopedic Regeneration
Dr. Tasciotti earned his B.S. in Biological Sciences and his M.S. in Molecular Biology at Scuola Normale Superiore Pisa, Italy and a Ph.D. in Molecular Medicine from a joint program of the Scuola Normale Superiore Pisa with the International Center for Biotechnology and Genetic Engineering (ICGEB) in 2004. Dr. Tasciotti research as a PhD student focused on gene and stem cell therapy of cancer. He moved to the United States in 2006 as a senior postdoctoral fellow in the Department of Nanomedicine and Biomedical Engineering at the University of Texas Health Science Center at Houston. There, Dr. Tasciotti expanded his research to material science and nanotechnology and to their applications in the fields of early diagnostics, drug delivery and regenerative medicine. As a postdoctoral fellow he carried his research in molecular imaging of angiogenesis and cancer development at the Center of Molecular Medicine and in cancer nanomedicine at the Department of Biomedical Engineering at the University of Texas Health Science Center. There, he laid the groundwork of two nanotechnology platforms: protein nanochips for the early detection of diseases, and nanoporous silicon particles for the targeted delivery of therapeutics. The latter was featured on the cover of Nature Nanotechnology and paved the way for a field of investigation called the Multistage Delivery Approach, which was selected as one of the “Five big ideas for nanotechnology” by Nature Medicine in 2008.
In 2008, Dr. Tasciotti was appointed Assistant Professor in the Department of Nanomedicine at the University of Texas Medical School. There, he conceived and coordinated the research project: “BioNanoScaffold for post-traumatic osteo-regeneration”, and developed multifunctional biomaterials that provide immediate mechanical stabilization to bone fractures and promote bone tissue regeneration. This project was funded within the Fracture Putty program of the Defense Advanced Research Project Agency and has involved over 60 investigators from multiple institutions over the course of the last 5 years. Thanks to this project, Dr. Tasciotti established strong ties within the community of tissue engineering and regenerative medicine, particularly in the clinical fields of orthopedic, spine, maxillofacial, oral and dental surgery, and is now formalizing the clinical translation of this technology.
In 2010, he joined the Department of Nanomedicine at Houston Methodist Research Institute, where he serves as Co-Chair of the Department of Nanomedicine, Director of the Center for Regenerative Medicine, and Scientific Director of the Surgical Advanced Technology Lab. There, Dr. Tasciotti directs a large research operation, with 25 research staff and trainees involved in the development of innovative nanotechnology platforms and biomaterials for drug delivery and regenerative medicine. Dr. Tasciotti is an inventor on six U.S. patents, serves as reviewer for more than 20 scientific journals and is a frequent speaker at international meetings. He served from 2010 to 2012 as the president of the council of reviewers for the Italian Ministry of Health and is a regular member of National Institute of Health, US Department of Defense and NCI Innovative Molecular Analysis Technologies (IMAT) study sections.
-Biomimetic materials to improve tissue regeneration and modulate the immune response.
-Artificial biomimetic extracellular matrices for musculoskeletal drug delivery and regenerative medicine.
-Bio-inspired and cell-based delivery platforms for the active targeting of inflammation.
-Nanostructured hydrogels for the localized sustained release of clinically approved drugs.
-Development of new surgical procedures and clinical approaches using nano-based therapeutics.